Seagen (United States)

Seagen

How to Contact Seagen

About Seagen

Seagen (formerly Seattle Genetics), now part of Pfizer, pioneered antibody-drug conjugate (ADC) technology for cancer treatment. Key products include Adcetris (brentuximab vedotin) for Hodgkin lymphoma and other blood cancers, Padcev (enfortumab vedotin) for bladder cancer, and Tukysa (tucatinib) for HER2-positive breast cancer. Seagen’s ADC expertise continues advancing targeted cancer therapies through Pfizer.

Medications

Medications Manufactured by Seagen

Experienced a Side Effect?

Report to

👉
Yellowcard logo
(UK)
👉
Medwatch logo
(US)
Now Patient SideEffects